Document Detail


Persistency of neutralizing antibodies depends on titer and interferon-beta preparation.
MedLine Citation:
PMID:  22013146     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Backround: Neutralizing antibodies (NAbs) affect the efficacy of interferon-beta (IFNβ) treatment in multiple sclerosis (MS) patients, particularly if NAbs persist. Persistency depends on NAb titers, which differ between IFNβ preparations. Objective: This study evaluated IFNβ preparation-specific NAb cut-off titers during early treatment for prediction of NAb persistency. Methods: Patients who had at least one NAb test between 12 and 30 months (baseline) as well as after more than 48 months (follow-up) on IFNβ treatment were included in this longitudinal study. Results: At baseline 1064 patients had a NAb test. Of those, 203 had a follow-up test. In the follow-up group 23.2% of patients were NAb positive during baseline. NAb frequency significantly decreased by 40.7% in the IFNβ-1a and by 60% in the IFNβ-1b group at follow-up after a mean time of 75.4 months on treatment, and median NAb titers decreased significantly in both groups. During baseline, NAb titers of >258 neutralizing units (NU) had a sensitivity of 81.3% and a specificity of 90.9% in the IFNβ-1a group, whereas titers of >460 NU had a sensitivity of 100% and a specificity of 91.7% in the IFNβ-1b group to predict persistency at follow-up. When these cut-off titers are applied, 10.2% of all treated patients developed persistent NAbs. Conclusion: IFNβ preparation-specific NAb cut-off titers for prediction of NAb persistency, which may be useful in individual treatment decision making, are provided.
Authors:
Harald Hegen; Manuel Schleiser; Claudia Gneiss; Franziska Dipauli; Rainer Ehling; Bettina Kuenz; Andreas Lutterotti; Thomas Berger; Florian Deisenhammer
Related Documents :
25195416 - Effect of broadcast baiting on abundance patterns of red imported fire ants (hymenopter...
22080196 - A prospective clinical study in hepatitis b e antigen-negative chronic hepatitis b pati...
22004186 - Ranibizumab therapy for choroidal neovascularisation secondary to non-age related macul...
22131716 - The role of apamarga kshara in the treatment of arsha.
760766 - The effect of danazol on menorrhagia, coagulation mechanisms, haematological indices an...
24670696 - Risk factors for treatment default in close contacts with latent tuberculous infection.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-19
Journal Detail:
Title:  Multiple sclerosis (Houndmills, Basingstoke, England)     Volume:  -     ISSN:  1477-0970     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9509185     Medline TA:  Mult Scler     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Clinical Department of Neurology, Innsbruck Medical University, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Paediatric multiple sclerosis: examining utility of the McDonald 2010 criteria.
Next Document:  Non-IgE-Mediated Cow Milk Allergy Is Linked to Early Childhood Clusters of Commonly Seen Illnesses: ...